Introduction {#s1}
============

T-type Ca^2+^ channels (TTCCs or Cav3) belong to one of the families of voltage-dependent Ca^2+^ channels. These channels are activated and inactivated at low membrane potentials (the threshold is about −60 mV) with rapid time-dependent decay (**t**ransient) and **t**iny single channel currents and thus termed **T**-type. They are encoded by three genes, Cav3.1 (α1G), Cav3.2 (α1H) and Cav3.3 (α1I) [@pone.0039965-Akaike1], [@pone.0039965-Nilius1], [@pone.0039965-PerezReyes1], [@pone.0039965-PerezReyes2], [@pone.0039965-PerezReyes3]. The identification of the genes encoding TTCCs [@pone.0039965-Nilius1], [@pone.0039965-PerezReyes1], [@pone.0039965-PerezReyes3] allows the examination of the properties, distribution and function of each subtype of TTCCs and offers the potential to design isoform-specific TTCC antagonists to treat related channelopathies.

TTCCs are present in a wide variety of tissues including the heart, brain, skeletal muscle, testis and spermatids, indicating multiple functions of these channels such as cardiac rhythm generation, neuronal excitability, hormone secretion, neurotransmitter release, vascular tone regulation, muscle contraction, gene expression, cell metabolism, differentiation, and proliferation [@pone.0039965-Nilius1], [@pone.0039965-PerezReyes1], [@pone.0039965-PerezReyes3], [@pone.0039965-Shuba1]. Therefore, abnormal expression and function of TTCCs are associated with many diseases including cardiac hypertrophy and arrhythmia, hypertension, epilepsy, autism, and cancer [@pone.0039965-Shuba1].

TTCCs are expressed in the whole heart during the embryonic stage but their expression in the ventricle decreases rapidly after birth [@pone.0039965-Mangoni1]. Cav3.1 and Cav3.2 expression is retained in the sinoatrial node (SAN), atrioventricular node (AVN) and Purkinje fibers of the adult heart, indicating a role in cardiac automaticity and conduction [@pone.0039965-Mangoni1]. Mice deficient of Cav3.2 showed normal sinoatrial rhythm [@pone.0039965-Chen1], but mice lacking Cav3.1 had prolonged SAN recovery time, slowed pacemaker activity of SAN cells and heart rate, and delayed atrioventricular conduction. These results indicate Cav3.1, rather than Cav3.2, is the major TTCC participant in cardiac rhythm generation in the mouse heart [@pone.0039965-Mangoni2].

Since β-adrenergic system is critical for heart rate regulation and Cav3.1 is involved in cardiac rhythm generation, it is important to examine the regulation of the TTCC by the β-adrenergic/PKA system. The regulation of TTCCs by cAMP-dependent protein kinase A (PKA) has been controversial probably due to the differences in experimental conditions, cell types and the existence of specific isoforms [@pone.0039965-Chemin1]. In general it is believed that PKA has little effects on TTCCs [@pone.0039965-Bean1], [@pone.0039965-Fisher1], [@pone.0039965-Benham1]. Phosphorylation of Cav3.2 by PKA has been shown to permit the inhibitory effect of Gβγ dimmers [@pone.0039965-Hu1]. In contrast, T-type Ca^2+^ current (I~Ca-T~, probably through Cav3.2 because it was sensitive to low concentration of Ni^2+^) in frog atrial myocytes was reported to be increased by isoproterenol via a cAMP/PKA independent mechanism [@pone.0039965-Alvarez1]. The same group showed that cAMP/PKA downstream to β-adrenergic receptor might phosphorylate a protein to enhance high-voltage prepulse-induced facilitation of TTCCs [@pone.0039965-Alvarez2]. In addition, Lenglet et al. also reported that Cav3.2 TTCC activity recorded in rat glomerulosa cells was augmented by PKA after the stimulation of 5HT7 receptors [@pone.0039965-Lenglet1]. To date, there is no report of the regulation of Cav3.1 by the β-adrenergic receptor/cAMP/PKA cascade in cardiac or other native mammalian cells.

In this study, we sought to determine whether Cav3.1 is regulated by β-adrenergic receptor/PKA signaling pathway using ventricular myocytes from Cav3.1 transgenic mice and sinoatrial node cells from wildtype or Cav3.2 knockout mice. We have found that the activity of both overexpressed and native Cav3.1 channel is enhanced by a β-adrenergic agonist, isoproterenol. This effect was mediated by the adenylyl cyclase/cAMP/PKA system because cAMP recapitulated the effect of isoproterenol while a PKA inhibitor (H89) abolished the effect of ISO on I~Ca-T(3.1)~. The upregulation of Cav3.1 by PKA may contribute to the regulation of the heart rate by the β-adrenergic system.

Materials and Methods {#s2}
=====================

Ethical Approval {#s2a}
----------------

This study conforms to the *Guide for the Care and Use of Laboratory Animals* published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) and was approved by the Institutional Animal Use and Care Committee at Temple University.

Animal Models {#s2b}
-------------

A mouse model with cardiac-specific (α-MHC controlled) and conditional (tet-off, controlled by doxycycline, DOX) overexpression of mouse Cav3.1 (Genebank: NM_009783) was established with the bitransgenic system developed by Sanbe A et al [@pone.0039965-Sanbe1]. Cav3.1 transgenic (TG) mice were used for isolating ventricular myocytes (VMs). Cav3.1 knockout and Cav3.2 knockout mouse colonies were obtained from the Molkentin's group [@pone.0039965-Nakayama1] for isolating the SAN cells.

Ventricular Myocyte and Sinoatrial Node Cell Isolation {#s2c}
------------------------------------------------------

Mouse ventricular myocytes (VMs) were isolated using a constant-pressure Langendorff apparatus as described [@pone.0039965-Zhou1]. Animals were anesthetized with sodium pentobarbital (120 mg/kg body weight). The heart was excised and digested via retrograde perfusion of the heart with normal Tyrode solution containing type II collagenase (290 U/mL) and (in mM): CaCl~2~ 0.02, glucose 10, HEPES 5, KCl 5.4, MgCl~2~ 1.2, NaCl 150, sodium pyruvate 2 (pH 7.4 with NaOH). After 8--10 min, the ventricles were minced and isolated ventricular myocytes were dissociated by gentle aspiration of minced tissue. Isolated VMs then were filtered with a 200 µm-diameter mesh. VMs were maintained in normal Tyrode solution containing 0.5% bovine serum albumin and the extracellular Ca^2+^ was titrated up to 1 mM. Myocytes were used within 8 hours after isolation.

SAN cells were isolated as described previously [@pone.0039965-Wu1], [@pone.0039965-Mangoni3]. Animals were anesthetized with sodium pentobarbital (120 mg/kg BW, intraperitoneal injection) and heparinized intravenously. SAN cells were isolated with a "chunk" technique as follow: After the heart was excised, it was placed into Tyrode's solution (35°C) containing (in mM) 140 NaCl, 5.0 HEPES, 5.5 Glucose, 5.4 KCl, 1.8 CaCl~2~, 1.0 MgCl~2~ (pH = 7.4). The SAN region was the one with spontaneous activity and where the contraction of the heart initiates. The SAN tissue was dissected out with a dissecting scope according to the landmarks of the heart (delimited by the orifice of superior vena cava, crista terminalis and atrial septum) as described [@pone.0039965-Wu1], [@pone.0039965-Mangoni3]. The SAN tissue was cut into smaller pieces, which were transferred and rinsed in a "low Ca^2+^" digestion containing (mM) 140 NaCl, 5.0 Hepes, 5.5 Glucose, 5.4 KCl, 0.2 CaCl~2~, 0.5 MgCl~2~, 1.2 KH~2~PO~4~, 50 Taurine, and 1 mg/mL BSA (pH = 6.9). Then SAN tissue pieces were digested in 5 mL of "low Ca^2+^" solution containing collagenase type I (Worthington, 225 U/mL), elastase (Worthington, 1.8 U/mL), and protease type XIV (0.8 U/mL, Sigma) for 30 min at 37°C. After digestion, the tissue was washed with 10 mL of Kraft-Bruhe medium containing (mM) 100 potassium glutamate, 5.0 Hepes, 20 Glucose, 25 KCl, 10 potassium aspartate, 2.0 MgSO~4~, 10 KH~2~PO~4~, 20 taurine, 5 creatine, 0.5 EGTA, and 1 mg/mL BSA (pH = 7.2) for 3 times and then the cells were dissociated with a transfer pipette by pipetting up and down the tissue chunks. Dissociated cells were put at room temperature for 5 min. The cells were stored at 4°C and studied within 5 hours.

Electrophysiology {#s2d}
-----------------

Ca^2+^ currents (I~Ca~) were measured using whole-cell voltage-clamp techniques with an Axopatch 2B voltage-clamp amplifier and pClamp8 software and 1--3 MΩ pipettes. Ca^2+^ currents were measured under discontinuous voltage-clamp mode. The real clamping voltage and Ca^2+^ currents were measured simultaneously. To achieve good voltage control, the gain was set between 8 to 50. To ensure the quality of our data, only data with the loss of voltage control \<10 mV were included for our report. VMs were placed in a heated chamber (35±2°C or room temperature) on the stage of an inverted microscope (Nikon Diaphot, Japan) and initially perfused with normal Tyrode solution. The pipette contained a Na^+^-free and K^+^-free solution consisting of (in mM): Cs-aspartic acid 130, EGTA 10, MgCl~2~ 1, NMDG 10, HEPES 10, TEA-Cl 20, Tris-ATP 5, Tris-GTP 0.25, pH 7.2. Once a gigaohm seal was obtained, the patched membrane was ruptured to allow 10 minutes of dialysis of the myocyte. The perfusate was switched to a Na^+^-free, K^+^-free solution containing (in mM): CaCl~2~ 2, 4-aminopyridine (4-AP) 2, CsCl 5.4, Glucose 10, HEPES 5, MgCl~2~ 1.2, NMDG 150, pH 7.4. Myocyte capacitance was obtained with the membrane test function in Clampex 8.0, which hyperpolarizes the cell for −5 mV from the holding potential to measure cell capacitance. The total calcium current (I~Ca~)-voltage relationship was determined by measuring I~Ca~ from a holding potential of −90 mV using square wave pulses in a 10 mV- increment. I~Ca-L~ was measured at the same test voltages from a holding potential of −50 mV. To minimize run-down of Ca^2+^ currents, these two Ca^2+^ currents measured at the same test potential were separated by a 1000 ms holding potential of −50 mV ([**Figure 1B**](#pone-0039965-g001){ref-type="fig"}) and 20 s was set between sweeps. I~Ca-T~ at each test membrane potential was determined by subtracting raw I~Ca-L~ from raw total I~Ca~ at this test potential, which is a traditional way for measuring I~Ca-T~ [@pone.0039965-Akaike1]. Mibefradil (1 µM) or BayK 8644 (1 µM) was applied via perfusate to the cell while the Ca^2+^ currents measured at the test potential −40 mV from the Vh of −90 mV and at 10 mV from the Vh of −50 mV to 10 mV were continuously monitored. BayK 8644, a DHP agonist, was selected because it could readily and affirmatively determine if BayK 8644 had any stimulatory effect on I~Ca-T~ even in the presence of a rundown of I~Ca-T~.

![I~Ca-T(3.1)~ was expressed only in Cav3.1 TG ventricular myocytes and sensitive to mibefradil but not to dihydropyridines.\
**A**, A schematic of the bitransgenic inducible expression system for cardiac-specific Cav3.1 overexpression. tTA is the tetracycline-controlled transactivator system. tetR, tet-repressor cDNA fused to VP16 (activator domain); tet-O, tet-operon. **B**, Raw currents of total I~Ca~, I~Ca-L~ and I~Ca-T~ in a control and a TG VMs. No I~Ca-T~ was present in this control cell but robust I~Ca-T~ found in the TG VM. **C & D**, Averaged I--V curves of total I~Ca~, I~Ca-L~ and I~Ca-T~ in control (n = 12) and TG (n = 13) ventricular myocytes. No I~Ca-T~ was detected in control VMs but great I~Ca-T~ found in TG VMs.](pone.0039965.g001){#pone-0039965-g001}

To determine ISO effect on the current-voltage (I--V) relationships of I~Ca-L~ and I~Ca-T~, I--V relationships of total I~Ca~ and I~Ca-L~ were recorded at baseline. Subsequently, 1 µM isoproterenol (ISO, Sigma) were applied through perfusate while the currents elicited from the Vh = −90 mV to −40 mV (mostly I~Ca-T~) and from the V~h~ = −50 mV to 10 mV (mostly I~Ca-L~) were monitored until the maximum effect of ISO was observed. Then, the I--V relationships of total I~Ca~, I~Ca-L~ and I~Ca-T~ were determined again as described above. To determine if direct activation of PKA was able to regulate I~Ca-T~, a nonhydrolyzable cAMP analog (dibutyryl-cAMP, Sigma, 10 µM) was dialyzed into the cell for 10 minutes and the I~Ca-L~ and I~Ca-T~ were determined afterwards [@pone.0039965-Chen2]. To determine if ISO effects on I~Ca-L~ and I~Ca-T~ is mediated by PKA, a PKA inhibitor (H89, Sigma, 5 µM), was included in the pipette filling solution and patched VMs were dialyzed for 10 minutes. Thereafter, the I--V relationships of total I~Ca~, I~Ca-L~ and I~Ca-T~ were measured before and after the application of ISO.

To investigate the effects of ISO and db-cAMP on voltage-dependent inactivation of I~Ca-L~ and I~Ca-T(3.1)~, double-pulse protocols were applied with or without these drugs. For I~Ca-T(3.1)~, the first pulse was the prepulse to different test voltages (−110 mV to −10 mV in a10 mV-increment) from the holding potential −90 mV. The second pulse was separated by a 5 ms repolarizing period to −90 mV from the prepulses and depolarized to −40 mV, a voltage almost only I~Ca-T~ and minimal I~Ca-L~ contamination could be recorded. For I~Ca-L~, the prepulses were evoked from the holding potential of −50 mV to different membrane potentials and the second pulse was evoked from a short return to −50 mV for 5 ms to 0 mV (for 400 ms).

Since in small SAN cells, rundown of I~Ca-L~ and I~Ca-T~ was faster (often I~Ca-T~ was decreased by \>30% within 10 minutes), it became a significant issue to study ISO effects if a long recording time was needed. Full I--V curves before and after ISO could not obtained. Therefore, to study ISO effects on I~Ca-T~ in SAN cells, we only studied ISO effect at a single voltage (from the holding potential of −90 mV to −40 mV) in the presence of nifedipine (an I~Ca-L~ blocker, 10 µM). The use of nifedipine ensured only I~Ca-T~ was recorded at this voltage even ISO could shift the activation of I~Ca-L~ to more negative voltage and thus avoided the use of double pulses to minimize recording time to minimize I~Ca-T~ rundown.

The conductance of L- and T-type Ca^2+^ channels (G~Ca~) was calculated by dividing the current by the driving force (V~t~-E~Ca~', where E~Ca~' stands for the apparent reversal potential of Ca^2+^). The activation-voltage (G-V) relationships were plotted using normalized L- or T-type Ca^2+^ channel conductance (G~Ca~/G~Ca,max~) as the y-axis and test potentials as the x-axis. The G-V curve is fitted with a Boltzmann function G/G~max~ = 1/\[1+exp\[−(V~t~−V~0.5,\ d∞~)/*k*\]\], where V~t~ is the test voltage and V~0.5,\ d∞~is the voltage at which half of the G~max~ can be elicited, *k* is the slope factor. The voltage-dependent inactivation curve (f~∞~) was fitted with a Boltzmann function G/G~max~ = 1/\[1+exp\[−(V~t~−V~0.5,\ f∞~)/*k*\]\], where V~t~ is the test voltage and V~0.5,\ f∞~is the voltage at which half of the channels were inactivated, *k* is the slope factor.

Real-time PCR {#s2e}
-------------

SAN tissue was pooled from 4--8 mice for wild type (n = 24) and transgenic (n = 19) animals. Total mRNA was extracted from snap-frozen SAN tissue, ventricular tissue, or brain (as a positive control for T-type Ca^2+^ channel expression) using Trizol reagent and quantitated by a UV spectrometer. Real-time PCR was done with the SYBR Green Real Time PCR kit (Applied Biosystems, Carlsbad, CA) according to the instruction of the kit and an Eppendorff Mastercycler RT-PCR machine. GAPDH was used as the internal control. The ΔΔCt-method was used to determine the abundance of Cav3 mRNAs relative to GAPDH. The primers were (5′ to 3′): **Cav3.1**: forward: TGTGGAAATGGTGGTGAAGA and reverse: ACTGCGGAGAAGCTGACATT; **Cav3.2**: forward: GCTGTTTGGGAGGCTAGAAT and reverse: CGAAGGTGACGAAGTAGACG; **Cav3.3**: forward: TGGGCATTTTTGGCAAGAA and reverse: CAGTGCGGATGGCTGACA; **GAPDH**: forward: TGCACCACCAACTGCTTAG and reverse: GATGCAGGGATGATGTTC.

Data Analysis {#s2f}
-------------

Obtained data were analyzed offline with Clampfit 8 (Molecular Device, CA) as described previously [@pone.0039965-Chen2], managed with Microsoft Excel and presented with GraphPad Prizm 5.0 (La Jolla, CA, USA). In short, I~Ca-T~ was obtained by subtracting the raw I~Ca-L~ from the raw total I~Ca~ as described previously [@pone.0039965-McDonald1]. The current-voltage (I--V) relationships were constructed by plotting the peak amplitudes of total I~Ca~, I~Ca-L~ and derived I~Ca-T~ against the test voltages.

Statistics {#s2g}
----------

Data in the text are reported as mean±SEM. When appropriate, paired and unpaired T-test, ANOVA or ANOVA for repeated measures were used to detect significance with SAS 9.0 (SAS Institute Inc.). P values of ≤0.05 were considered significant. In this paper, *n* is the number of cells examined from at least 3 animals.

Results {#s3}
=======

Cav3.1 Mediated T-type Ca^2+^ Current (I~Ca-T(3.1)~) Was Observed Only in VMs from Cav3.1 Double Transgenic Mice {#s3a}
----------------------------------------------------------------------------------------------------------------

To examine whether Cav3.1 was expressed in our transgenic system, I~Ca-T~ was measured in VMs from transgenic (TG) and control hearts. Typical examples of total Ca^2+^ current (I~Ca~), L-type Ca^2+^ current (I~Ca-L~) and T-type Ca^2+^ current (I~Ca-T~) in control and TG VMs are shown in [**Figure 1B**](#pone-0039965-g001){ref-type="fig"}. The current-voltage relationships **(**I--V curves) of total I~Ca~, I~Ca-L~ and I~Ca-T~ in both control (n = 12) and TG myocytes (n = 5) are shown in [**Figure 1C** and **D**](#pone-0039965-g001){ref-type="fig"}. There was no detectable I~Ca-T~ observed in all 12 tested control cells ([**Figure 1B and C**](#pone-0039965-g001){ref-type="fig"}) but a great density of I~Ca-T~ (maximum I~Ca-T~ amplitude: −12.1±1.3pA/pF) was found in Cav3.1 TG VMs ([**Figure 1B and D**](#pone-0039965-g001){ref-type="fig"}). I~Ca-T~ had a threshold of ∼−60 mV and peaked at ∼−40 mV. The time-dependent decay rates (kinetics) of the I~Ca-T~ were significantly faster than those of the I~Ca-L~ recorded in the same cell ([**Figure 1B**](#pone-0039965-g001){ref-type="fig"}), as reported previously [@pone.0039965-Akaike1].

To confirm the identity of putative I~Ca-T~, mibefradil (1 µM) was used to determine its sensitivity to this TTCC antagonist. Mibefradil suppressed I~Ca-T~ at −40 mV by 66.8±8.7% ([**Figure 2A and C**](#pone-0039965-g002){ref-type="fig"}) but had minimal effect on I~Ca-L~ at 10 mV (decreased by 11.1±2.8%; [**Figure 2B and D**](#pone-0039965-g002){ref-type="fig"}). To further confirm that I~Ca-T~ could be effectively separated by holding the cell at different membrane potentials with minimal contamination of I~Ca-L~, BayK 8644, a dihydropyridine agonist specific for I~Ca-L~, was used to test dihydropyridine effect on the two components of I~Ca~. As suggested in [**Figure 1C** and **D**](#pone-0039965-g001){ref-type="fig"}, I~Ca~ recorded at −40 mV from V~h~ of −90 mV was almost completely consisting of I~Ca-T~ while I~Ca~ recorded at 10 mV from V~h~ of −50 mV should be only I~Ca-L~. As predicted, I~Ca~ at −40 mV from the V~h~ of −90 mV was not changed by BayK ([**Figure 2E, F and H**](#pone-0039965-g002){ref-type="fig"}) while I~Ca~ at 10 mV from the V~h~ of −50 mV was significantly increased 49.7±0.8% by BayK ([**Figure 2E, G and H**](#pone-0039965-g002){ref-type="fig"}). When the I--V curves of presumable I~Ca-L~ and I~Ca-T~, separated by the strategy of holding the cell at different membrane potentials, were examined, BayK evidently increased the presumable I~Ca-L~ but not the presumable I~Ca-T~ ([**Figure 2I, J and K**](#pone-0039965-g002){ref-type="fig"}). These results suggest that the separation of I~Ca-L~ and I~Ca-T~ by holding the cell at different membrane potentials is effective, and that I~Ca-T~ is not sensitive to dihydropyridines but sensitive to mibefradil.

![I~Ca-T(3.1)~ in Cav3.1 TG ventricular myocytes was sensitive to mibefradil but not to dihydropyridines.\
**A** & **B**, Time courses of amplitude changes of presumable I~Ca-L~ and I~Ca-T~ in response to mibefradil. **C & D**, Relative changes of ICa-T (**C**) and ICa-L (**D**) in response to mibefradil. **E**, Raw currents recorded at −40 mV from Vh = −90 mV and at 10 mV from Vh = −50 mV before and after the application of BayK 8644. **F & G**, Time courses of amplitude changes of presumable I~Ca-L~ and I~Ca-T~ in response to BayK. **H**, Normalized increases in presumable I~Ca-L~ and I~Ca-T~ by BayK. **I**, **J and K**, I--V curves of total I~Ca~, I~Ca-L~ and I~Ca-T~ before and after BayK.](pone.0039965.g002){#pone-0039965-g002}

ISO Significantly Increased I~Ca-T(3.1)~ in TG VMs {#s3b}
--------------------------------------------------

To study whether I~Ca-T(3.1)~ can be regulated by the β-adrenergic system in cardiac myocytes, isoproterenol, a β-adrenergic agonist, was applied to TG VMs. Since I~Ca~ at −40 mV from the V~h~ of −90 mV was almost completely consisting of the T-type Ca^2+^ current, ISO effect on I~Ca-T(3.1)~ was monitored by recording I~Ca~ at −40 mV. [**Figure 3A**](#pone-0039965-g003){ref-type="fig"} showed I~Ca~ at −40 mV before and after ISO and [Figure **3B**](#pone-0039965-g003){ref-type="fig"} showed the time course of the ISO effect on a myocyte, suggesting a significant upregulation of I~Ca-T(3.1)~. I--V curves of total I~Ca~ ([**Figure 3C**](#pone-0039965-g003){ref-type="fig"}), I~Ca-L~ ([**Figure 3D**](#pone-0039965-g003){ref-type="fig"}), and I~Ca-T~ ([**Figure 3E**](#pone-0039965-g003){ref-type="fig"}) before and after ISO showed that β-adrenergic stimulation (ISO) significantly increased both I~Ca-L~ and I~Ca-T~ at most test voltages. The maximal I~Ca-L~ was increased by 81.6% (from −7.6±1.2pA/pF to −13.8±1.3pA/pF) and the maximal I~Ca-T(3.1)~ was increased by 55.5% (from −12.8±1.9pA/pF to −19.9±2.4pA/pF). It is well known that β-adrenergic stimulation shifts the activation of I~Ca-L~ to more negative voltages and accelerates the decay of I~Ca-L~ via a Ca^2+^-dependent inactivation mechanism [@pone.0039965-McDonald1]. In this study, we found that ISO shifted the peak I~Ca~ voltage for I~Ca-L~ but not for I~Ca-T(3.1)~ ([**Figure 3D and E**](#pone-0039965-g003){ref-type="fig"}). It seems that there is no voltage dependent effect of ISO because ISO did not change the voltage-dependence of I~Ca-T(3.1)~ activation and inactivation although it shifted the activation and inactivation of I~Ca-L~ to more negative voltages ([**Figure 3F and 3G**](#pone-0039965-g003){ref-type="fig"} **)**.

![ISO significantly increased I~Ca-T(3.1)~ and I~Ca-L~.\
**A**, Raw current recordings at −40 mV from the V~h~ of −90 mV before and after ISO. **B**, Time course of the change of the amplitude of I~Ca~ measured at the test potential of −40 mV from the V~h~ = −90 mV, which was almost completely consisting of I~Ca-T(3.1)~. **C-E**, Averaged I--V curves of total I~Ca~ (**C**), I~Ca-L~ (**D**), and I~Ca-T~ (**E**) before and after ISO application. ISO increased total I~Ca~, I~Ca-T~ and I~Ca-L~ at most membrane potentials. ISO shifted the voltage at which I~Ca-L~ peaked from 0 mV to −10 mV but did not change the voltage (−40 mV) at which I~Ca-T(3.1)~ peaked. **F** and **G**: the voltage-dependent activation and inactivation curves of I~Ca-L~ and I~Ca-T~ before and after the application of ISO. @: *p\<0.001;* \#: *p\<0.01; \$: p\<0.05;* TG vs. control at the same test potential. Statistics were done with two-way ANOVA and post-hoc t-test.](pone.0039965.g003){#pone-0039965-g003}

Nonhydrolyzable Dibutyryl-cAMP (db-cAMP) Significantly Increased I~Ca-T(3.1)~ at Both Physiological and Room Temperatures {#s3c}
-------------------------------------------------------------------------------------------------------------------------

The stimulatory effect of β-adrenergic agonists on calcium channels in cardiac myocytes can be mediated by mulitple mechanisms [@pone.0039965-McDonald1]: 1, PKA activation through the β-adrenergic receptor/Gαs/adenyl cyclase/cAMP/PKA pathway; 2, direct modulation by Gαs or Gβγ after the binding of adrenergic agonists to the adrenergic receptor and subsequent dissociation of Gαs from Gβγ dimer; 3. The newly found cAMP sensor, EPAC (exchange protein directly activated by cAMP), regulates I~Ca-T~. We tested if direct activation of PKA by a cAMP analog (db-cAMP) was able to stimulate I~Ca-T(3.1)~. Db-cAMP significantly increased I~Ca-L~ by 154.9% (with db-cAMP −15.5±3.3pA/pF versus without db-cAMP −6.1±0.8pA/pF, [**Figure 4B**](#pone-0039965-g004){ref-type="fig"}) and increased I~Ca-T(3.1)~ by 102.8% (with db-cAMP 22.7±2.6pA/pF vs. without db-cAMP −11.2±0.9pA/pF, [**Figure 4C**](#pone-0039965-g004){ref-type="fig"}). The voltage-dependence of I~Ca-T~ activation and inactivation was not altered by db-cAMP ([**Figure 4F**](#pone-0039965-g004){ref-type="fig"}) although db-cAMP shifted the activation curve and inactivation curve to the left ([**Figure 4E**](#pone-0039965-g004){ref-type="fig"}). These findings clearly show that the ISO effects of I~Ca-T(3.1)~ are recapitulated by cAMP, indicating that the upregulation of I~Ca-T(3.1)~ by ISO is mediated by the cAMP dependent PKA signaling pathway.

![A nonhydrolyzable cAMP analog, db-cAMP, significantly increases I~Ca-T~ and I~Ca-L~.\
**A**, Example currents of total I~Ca~, I~Ca-L~ and I~Ca-T~ without (top) or with db-cAMP (lower) in the pipette recorded in TG VMs. Currents were normalized to cell capacitance for comparison and the scale bars are the same for both without or with db-cAMP recordings. **B--D**, Averaged I--V curves of total I~Ca-total~ (**B**), I~Ca-L~ (**C**) and I~Ca-T~ (**D**) with or without db-cAMP in the pipette. There are significantly increases in both I~Ca-L~ and I~Ca-T(3.1)~. Db-cAMP shifted the peak voltage of I~Ca-L~ to more negative voltages but did not change that of I~Ca-T(3.1)~ in TG VMs. **E** and **F**: the voltage-dependent activation and inactivation curves of I~Ca-L~ and I~Ca-T~ with or without db-cAMP. @: *p\<0.001;* \#: *p\<0.01; \$: p\<0.05;* TG vs. control at the same test potential. Statistics were done with two-way ANOVA and post-hoc t-test.](pone.0039965.g004){#pone-0039965-g004}

The Effect of ISO on I~Ca-T\ (3.1)~ can be Blocked by a PKA Inhibitor, H-89 {#s3d}
---------------------------------------------------------------------------

Albeit our results with db-cAMP imply that the stimulatory effect of ISO might be mediated by PKA, recently another cAMP sensor, an exchange protein directly activated by cAMP (EPAC), has been found in cells from various tissues including the heart [@pone.0039965-Metrich1]. To rule out the involvement of EPAC and confirm the role of PKA in the stimulatory effects of ISO, a PKA-specific inhibitor, H89, was included in the pipette filling solution. In the presence of H89, ISO did not increase the current recording at the Vt = −40 mV from Vh = −90 mV (mainly I~Ca-T(3.1)~) before and after the application of ISO (raw currents in [**Figure 5A**](#pone-0039965-g005){ref-type="fig"} and time course in [**Figure 5B**](#pone-0039965-g005){ref-type="fig"}). I--V curves of I~Ca-L~ and I~Ca-T~ were not changed by ISO with H89 in the pipette filling solution ([**Figure 5C & D**](#pone-0039965-g005){ref-type="fig"}). These results support the idea that PKA activated by β-adrenergic agonists causes the upregulation of I~Ca-T(3.1)~.

![The effect of ISO on I~Ca-T~ and I~Ca-L~ can be blocked by a PKA Inhibitor, H89.\
**A**, Raw currents evoked from the holding potential of −90 mV to −40 mV before and 4 minutes after the application of ISO in a TG myocyte dialyzed with pipette H89 (10 µM). **B**, The time course of the change of the amplitude of I~Ca-T(3.1)~ (recorded at V~t~ = −40 mV from the V~h~ = −90 mV). H89 blocked the effect of ISO on I~Ca-T(3.1)~. **C &** **D**, Averaged I--V curves of I~Ca-L~ and I~Ca-T~ in TG VMs dialyzed with H89 before and after the application of ISO.](pone.0039965.g005){#pone-0039965-g005}

I~Ca-T(3.1)~ is the T-type Ca^2+^ Current in Mouse SAN Cells and is Upregulated by Isoproterenol {#s3e}
------------------------------------------------------------------------------------------------

At last, we examined if native I~Ca-T~ in SAN cells is regulated by the β-adrenergic system. Total I~Ca~, I~Ca-T~ and I~Ca-L~ were recorded from wild type and Cav3.1 KO SAN cells. In wild type SAN cells, I~Ca-T~ was clearly recorded with a maximum current of −2.08±0.64pA/pF ([**Figure 6**](#pone-0039965-g006){ref-type="fig"} **A--C**). In contrast, in the SAN cells from Cav3.1 knockout mice, T-type Ca^2+^ current is completely absent, indicating that Cav3.1 is the major mediator of I~Ca-T~ in mouse SAN cells ([**Figure 6**](#pone-0039965-g006){ref-type="fig"} **D--F**) as previous study suggests [@pone.0039965-Mangoni2]. Real-time PCR further confirmed that the major TTCC in the SAN is Cav3.1. Cav3.2 mRNA abundance was very low and Cav3.3 mRNA was not detectable in SAN tissue although all three types of TTCCs were detected in the brain ([**Figure 6**](#pone-0039965-g006){ref-type="fig"} **G**). I~Ca\ (~presumably I~Ca-T~) measured at −40 mV in wild-type SAN cells bathed in 10 µM nifedipine (to block I~Ca-L~) was increased by 115.7±21.1% with 1 µM ISO ([**Figure 6**](#pone-0039965-g006){ref-type="fig"} **H and I**). To further make sure that I~Ca-T~ in SAN cells was Cav3.1-mediated and could be stimulated by 1 µM ISO, I~Ca-T~ was recorded in Cav3.2 knockout SAN cells and ISO did increase I~Ca-T~ in these cells by 161.0±20.5% ([**Figure 6**](#pone-0039965-g006){ref-type="fig"} **J and K**).

![I~Ca-T~ in mouse SAN cells is mediated by Cav3.1 and can be increased by ISO.\
I--V curves of total I~Ca~, I~Ca-L~ and I~Ca-T~ in wild-type control (**A, B and C**) and in Cav3.1 knockout (**D, E and F**) SAN cells were shown in **A-F**, showing I~Ca-T~ is present in WT cells but not Cav3.1 KO cells. **G**, mRNA abundance of Cav3.1, Cav3.2, Cav3.3 in wildtype brain, wildtype ventricle, wildtype SAN, Cav3.1 TG brain, Cav3.1 TG ventricle, and Cav3.1 TG SAN, measured by real-time PCR. **H and J**, time courses of the change of I~Ca-T~ (recorded at −40 mV in the presence of nifedipine) amplitudes by ISO+nifedipine in control wildtype (**H**) and Cav3.2 KO (**J**) SAN cells. **I and K**, normalized increases of I~Ca-T~ (recorded at −40 mV in the presence of nifedipine) by ISO+nifedipine in control wildtype (**I**) and Cav3.2 KO (**K**) SAN cells.](pone.0039965.g006){#pone-0039965-g006}

Discussion {#s4}
==========

What are the New Findings in this Study? {#s4a}
----------------------------------------

First, we found that β-adrenergic stimulation increased I~Ca-T(3.1)~ in cardiac myocytes expressing exogenous or endogenous Cav3.1 channels. To our knowledge, this is the first detailed study of β-adrenergic regulation of one specific subtype of TTCCs in cardiac myocytes thus far. Second, the cAMP/PKA pathway mediates the activity enhancing effect of β-adrenergic stimulation.

The Regulation of TTCCs by the β-adrenergic/PKA Pathway {#s4b}
-------------------------------------------------------

TTCCs are distributed in various cell types serving a wide range of functional roles [@pone.0039965-PerezReyes1], [@pone.0039965-Lory1]. Abnormal expression of T-type Ca^2+^ channels is involved in pathological conditions including epilepsy [@pone.0039965-Tsakiridou1], neurogenic pain [@pone.0039965-Kim1], cancer [@pone.0039965-Adams1], [@pone.0039965-Taylor1], and cardiac hypertrophy [@pone.0039965-Nuss1]. Therefore, the regulation of TTCCs has been studied since their discoveries [@pone.0039965-Chemin1]. However, early studies often show conflicting results possibly due to unknown molecular identities and TTCC heterogeneity in cells [@pone.0039965-Chemin1]. Interestingly, it has been shown that the same neurotransmitter, hormone, or protein kinase exerts different effects on subtypes of TTCCs or on the same TTCC subtype in different tissues [@pone.0039965-Chemin1]. In addition, in our study, we have observed a run-down phenomenon of I~Ca-T~ at baseline or during β-adrenergic stimulation in some myocytes, which could mask the stimulatory effects of β-adrenergic.

Specifically for β-adrenergic/PKA regulation of TTCCs, it remains controversial [@pone.0039965-Chemin2]. Most previous studies showed little effect of PKA on TTCCs [@pone.0039965-Bean1], [@pone.0039965-Fisher1], [@pone.0039965-Benham1]. Phosphorylation of Cav3.2 by PKA permits the inhibition of I~Ca-T~ by Gβγ dimmers [@pone.0039965-Hu1]. On the other hand, T-type Ca^2+^ current has been reported be increase by ISO in frog atrial cells through a cAMP/PKA-independent mechanism [@pone.0039965-Alvarez1] while in rat glomerulosa cells by 5-HT via a PKA-dependent mechanism [@pone.0039965-Lenglet1]. Cav3.2 channel activity can be increased by db-cAMP in heterologous systems as well [@pone.0039965-Chemin2], [@pone.0039965-Kim2]. To date, there has been no report about Cav3.1 regulation by β-adrenergic system, which is not present in heterologous systems. It has been shown that in the mouse heart, Cav3.1 is the primary TTCC found in SAN cells as our study also suggests [@pone.0039965-Mangoni2]. Here, for the first time, we have shown that in cardiac myocytes only expressing Cav3.1 (TG myocytes or Cav3.2 knockout SAN cells), I~Ca-T(3.1)~ was significantly increased by ISO. Db-cAMP reproduces the effect of ISO on I~Ca-L(3.1)~ at both room and physiological temperatures while H89 (a PKA inhibitor) blocked ISO effect on I~Ca-L~ and I~Ca-T~ in TG myocytes, confirming that the stimulatory effect of ISO on I~Ca-L~ and I~Ca-T~ is mediated by PKA.

Potential Mechanisms for PKA-dependent Upregulation of I~Ca-T(3.1)~ {#s4c}
-------------------------------------------------------------------

In the current study, we did not determine how I~Ca-T(3.1)~ is regulated by PKA activated by ISO. PKA might phosphorylate Cav3.1 directly as it does on L-type (Cav1) Ca^2+^ channels. Since it is generally believed that Cav3 channels do not have accessory subunits, the PKA site(s) could be on the Cav3.1α subunit. It is possible that PKA-dependent phosphorylation of Cav3.1 augments the open probability of the channel, as it does to the L-type Ca^2+^ channel. A second possibility is that PKA might phosphorylate another molecule to indirectly augment the open probability of the channel. Further studies will be needed to define the mechanism.

The effect of β-adrenergic stimulation on I~Ca-T~ could be reversed by dephosphorylation of Cav3.1α or a related protein if PKA phosphorylation is the mechanism for the upregulation of Cav3.1 activity. Multiple protein serine/threonine phosphatases including PP1, PP2A, and PP2B, are expressed in cardiac myocytes. Which phosphatase is involved in Cav3.1 by ISO warrants further investigation.

Relevance of β-adrenergic Mediated Upregulation of I~Ca-T(3.1)~ in the Heart {#s4d}
----------------------------------------------------------------------------

In the heart, T-type calcium channels contribute to the heart rate generation [@pone.0039965-Huc1], and it is possible that β-adrenergic/PKA regulation of Cav3.1 may participate in the positive chronotropic effects of β-adrenergic agonists. I~Ca-T~ is also reported to be reemerged and a participator in excitation-contraction coupling in stressed hearts; it is likely that β-adrenergic mediated upregulation of I~Ca-T~ might also contribute to cardiac contraction in stressed hearts although our previous studies have shown that overexpressed Cav3.1 is not effective to load the SR and trigger SR Ca^2+^ release [@pone.0039965-Jaleel1]. Furthermore, if there is abnormally high I~Ca-T~ (e.g., overstimulation of the Cav3 channels by the sympathetic nervous system) in the cardiac pacemaking tissues and the conduction system, there could be tachycardia or atrial fibrillation or ectopic ventricular contraction. We have observed ectopic ventricular contraction in some Cav3.1 TG mice. In line with this, blocking Cav3 channels is able to reduce arrhythmic events and sudden cardiac death in a mouse heart failure model [@pone.0039965-Kinoshita1].

Conclusion {#s4e}
----------

In cardiac myocytes, Cav3.1 current is increased by β-adrenergic agonists. This effect is mediated by protein kinase A. The regulation of Cav3.1 by β-adrenergic/PKA signaling pathway could play a role in heart rate regulation, arrhythmias and regulating other cellular functions involving Cav3.1.
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